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Abstract
We have developed NetPath as a resource of curated human signaling pathways. As an initial step, NetPath pro-
vides detailed maps of a number of immune signaling pathways, which include approximately 1,600 reactions
annotated from the literature and more than 2,800 instances of transcriptionally regulated genes - all linked to over
5,500 published articles. We anticipate NetPath to become a consolidated resource for human signaling pathways
that should enable systems biology approaches.
Background
Complex biological processes such as proliferation,
migration and apoptosis are generally regulated through
responses of cells to stimuli in their environment. Signal
transduction pathways often involve binding of extracel-
lular ligands to receptors, which trigger a sequence of
biochemical reactions inside the cell. Generally, proteins
are the effector molecules, which function as part of lar-
ger protein complexes in signaling cascades. Cellular sig-
naling events are generally studied systematically
through individual experiments that are widely scattered
in the biomedical literature. Assembling these individual
experiments and putting them in the context of a signal-
ing pathway is difficult, time-consuming and cannot be
automated.
The availability of detailed signal transduction path-
ways that can easily be understood by humans as well as
be processed by computers is of great value to biologists
trying to understand the working of cells, tissues and
organ systems [1]. A systems-level understanding of any
biological process requires, at the very least, a compre-
hensive map depicting the relationships among the var-
ious molecules involved [2]. For instance, these maps
could be used to construct a complete network of pro-
tein-protein interactions and transcriptional events,
which would help in identifying novel transcriptional
and other regulatory networks [3]. These can be
extended to predict how the interactions, if perturbed
singly or in combination, could affect individual biologi-
cal processes. Additionally, they could be used to iden-
tify possible unintended effects of a candidate
therapeutic agent on any clusters in a pathway [4]. We
have developed a resource called NetPath that allows
biomedical scientists to visualize, process and manipu-
late data pertaining to signaling pathways in humans.
Results and discussion
Development of NetPath as a resource for signal
transduction pathways
NetPath [5] is a resource for signaling pathways in
humans. As an initial set, we have curated a list of ten
immune signaling pathways. The list of immune signal-
ing pathways includes T and B cell receptor signaling
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pathways, as shown in Table 1. A query system facili-
tates searches based on protein/gene names or accession
numbers to obtain the list of cellular signaling pathways
involving the queried protein (Figure 1).
Signaling pathway annotation
To facilitate annotation of pathway data, we first devel-
oped a tool called ‘PathBuilder’ [6]. PathBuilder is a sig-
nal transduction pathway annotation tool that allows
annotation of pathway information, storage of data, easy
retrieval and export into community standardized data
structures such as BioPAX (Biological Pathways
Exchange) [7], PSI-MI (Proteomics Standards Initiative -
Molecular Interactions) [8] and SBML (Systems Biology
Markup Language) [9] formats. PathBuilder facilitates
the entry of information pertaining to protein interac-
tions, enzyme-regulated reactions, intracellular translo-
cation events and genes that are transcriptionally
regulated.
Protein-protein interactions could be binary when two
proteins directly interact with each other - ‘direct inter-
action’ - or when the proteins are present in a complex
of proteins - ‘complex interaction’. Both types of protein
interactions are comprehensively collected from the lit-
erature. We provide PubMed identifiers, experiment
type and host organism in which the interaction has
been detected.
Enzyme-regulated reactions such as post-translational
modifications (for example, phosphorylation, proteolytic
cleavage, ubiquitination, prenylation or sulfation) are
annotated as catalysis interactions. For each catalysis or
modification event, the upstream enzyme, downstream
targets and the site of the modification for a protein are
annotated, if available. Proteins that translocate from
one compartment (for example, the cytoplasm) to
another (for example, the nucleus) are represented as
transport events. For all reactions, a brief comment
describing the reaction is also provided.
Display of pathway information
The homepage of any given pathway contains a brief
description of the pathway, a summary of the reaction
statistics and a list of the molecules involved in the
pathway. Reactions in a pathway are provided under
three distinct categories, including physical interactions,
enzyme catalysis and transport. Furthermore, the path-
way data are also provided in PSI-MI, BioPAX and
SBML formats, which can also be visualized through
other external network visualization software, such as
Cytoscape [10].
Cataloging transcriptionally regulated genes
In addition to the above pathway annotations, informa-
tion on genes that are transcriptionally regulated is pro-
vided in NetPath. This is important because addition of
most extracellular growth factors or ligands leads to an
alteration in the transcriptome of the cell. Often, some
of the transcriptionally regulated genes are used as
‘reporters’ in biological experiments where the pathway
is being studied. We have cataloged a number of genes
that are up- or down-regulated by the particular ligand
involved in each pathway. These up/down-regulated
genes can be considered as ‘signatures’ for that particu-
lar pathway. We have incorporated both microarray and
non-microarray (for example, Northern blot, quantita-
tive RT-PCR, serial analysis of gene expression (SAGE),
and so on) experiments for gene expression. In each
case, the type of experiment (that is, microarray, non-
microarray or both) used to obtain the data is indicated.
Additionally, we have also annotated the transcription
factors that are responsible for transcriptional regulation
Table 1 Immune signaling pathway statistics
Pathway Molecular
association
events
Catalysis
events
Transport
events
Total
reactions
Number of upregulated
genes annotated
Number of
downregulated genes
annotated
Number of
PubMed links
1 T cell
receptor
202 215 13 430 453 178 1,153
2 B cell
receptor
172 136 43 351 253 182 990
3 IL-1 55 44 9 108 161 79 461
4 IL-2 68 76 11 155 539 301 1289
5 IL-3 65 52 5 122 43 10 250
6 IL-4 59 47 5 111 222 90 519
7 IL-5 26 40 6 72 167 9 308
8 IL-6 65 58 7 130 84 25 332
9 IL-7 14 39 2 55 57 14 175
10 IL-9 14 20 4 38 25 1 103
Total 10 740 727 105 1,572 2,004 889 5,580
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available. Given the large number of transcriptionally
regulated genes for each pathway, we have also devel-
oped a query system that permits users to search such
genes using gene symbol or accession numbers. This
feature will be valuable for shortlisting genes that are
common to several pathways or specific to any given
pathway.
Pathway statistics
At present the 10 annotated immune signaling pathways
comprise 703 proteins and 1,572 reactions. The reac-
tions can be grouped into 740 molecular association
events, 727 enzyme catalysis events and 105 transloca-
tion events. Our pathways provide a list of 2,004 and
889 genes that are up- or down-regulated, respectively,
at the level of mRNA expression. Including 10 cancer
signaling pathways that are also available through Can-
cer Cell Map [11], NetPath now contains 1,682 proteins
and 3,219 reactions, which can be grouped into 1,800
molecular association events, 1,218 enzyme catalysis
events and 201 transport events. Table 1 shows the
overall immune signaling pathway statistics as of 1
November 2009.
Comparison with other signaling databases
Although over 310 resources [12] provide some form of
pathway related information, many of these currently
available resources are databases for protein-protein inter-
actions, metabolic pathways, transcription factors/gene
regulatory networks, and genetic interaction networks.
Some of these pathways include the Kyoto Encyclopedia
of Genes and Genomes (KEGG) [13], BioCarta [14],
Science’s Signal Transduction Knowledge Environment
(STKE) Connections Maps [15], Reactome [16], National
Cancer Institute’s Pathway Interaction Database (PID)
[17], Pathway database from Cell Signaling Technology
[18], Integrating Network Objects with Hierarchies
(INOH) [19], Signaling Pathway Database (SPAD) [20],
GOLD.db [21], PATIKA [22], pSTIING [23], TRMP [24],
WikiPathways [25] and PANTHER [26]. However, many
of these pathway resources are not primary - that is, they
combine data from many other sources. Thus, we have
compared NetPath with eight other signaling pathways
Figure 1 The NetPath homepage. The search function allows users to query the database with multiple options, including gene symbol,
protein name, accession number and name of the pathway. The browse option links directly to a page listing all available pathways.
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derived from experiments. Of all these pathways that are
compared, NetPath stands out for three unique features.
The first is that it includes annotation of transcriptionally
regulated genes. Such a catalog of transcriptionally regu-
lated genes pertaining to a given pathway should be highly
useful in exploring pathway-specific expression signatures.
The second unique feature is that NetPath provides manu-
ally curated textual descriptions of each pathway reaction,
which should facilitate an easier understanding of these
pathways, aiding biomedical scientists to get an overview
of the pathway reactions in a central repository. The third
unique feature of NetPath is that these data can be
searched using SPARQL - the recommended query lan-
guage for the semantic web. Table 2 compares some of
the salient features of NetPath with some of the other
popular signaling pathway resources. In addition to the
unique features, NetPath also provides a separate molecule
page for every pathway component along with a brief tex-
tual description for each molecule. Overall, NetPath
should be a useful pathway resource with unique features
that should facilitate signaling research.
Interleukin-2 pathway as a prototype
One of the best studied immune signaling pathways is
the interleukin (IL)-2 signaling pathway [27]. IL-2 is a
multifunctional cytokine with pleiotropic effects on sev-
eral cells of the immune system [27,28]. IL-2 was origin-
ally discovered as a T cell growth factor [29], but it was
also found to have actions related to B cell proliferation
[30], and the proliferation and cytolytic activity of nat-
ural killer cells [31]. IL-2 also activates lymphokine acti-
vated killer cells [32]. In contrast to its proliferative
effects, IL-2 also has potent activity in a process known
as activation-induced cell death [33]. More recently, IL-
2 was shown to promote tolerance through its effects on
regulatory T cell development [34]. IL-2 clinically has
anti-cancer effects [35] as well as utility in supporting T
cell numbers in HIV/AIDS [36].
There are three classes of IL-2 receptors, binding IL-2
with low, intermediate, or high-affinity [37]. The low
affinity receptor (IL-2Ra alone) is not functional; signal-
ing by IL-2 involves either the high affinity hetero-tri-
meric receptor containing IL-2Ra,I L - 2 R b and the
common cytokine receptor gamma chain (originally
named IL-2Rg and now generally denoted as gc) or the
intermediate affinity heterodimeric receptor composed
of IL-2Rb and gc[ 3 7 , 3 8 ] .M u t a t i o n si nt h eIL2RG gene
result in X-linked severe combined immunodeficiency
disease [39]. IL-2 stimulation induces the activation of
the Janus family tyrosine kinases JAK1 and JAK3, which
associate with IL-2Rb and gc, respectively. These kinases
Table 2 Comparison of salient features of NetPath with other popular curated signaling pathway resources
Pathway
resource
Query
option for
pathway
molecules
Genes
transcriptionally
regulated by
pathway
included?
Pathways
reviewed
by
experts?
File formats
available for
download
Textual
description
of reactions
provided?
Other features or comments
NetPath [5] Yes Yes Yes BioPAX, PSI-MI,
SBML, Excel, Tab-
delimited
Yes Focus on human receptor mediated signaling.
Also contains separate molecule pages with
brief summary of the biology of the individual
molecules
BioCarta [14] Yes No Yes No download
option provided
No BioCarta provides commercial links to antibody
reagents
Science’s
STKE [15]
No No Yes SVG No Contains species-specific and also cell-type-
specific pathways
KEGG [13] Yes No No KGML, BioPAX No Contains disease specific pathways
Reactome
[16]
Yes No Yes BioPAX, SBML,
PDF, SVG,
Protégé, MySQL
database dump
Yes Also contains computationally inferred pathway
reactions
NCI-PID [17] Yes No Yes XML, BioPAX, SVG,
JPG
No Apart from NCI-Nature curated pathways, it
also contains many pathways imported from
BioCarta/Reactome
CST [18] Yes No Yes (in
some
cases)
PDF No Provides pathway information along with links
to protein and commercial products available
for that protein
WikiPathways
[25]
Yes No No GPML, GenMAPP,
PDF, PNG, SVG
No Any user can register and create a new
pathway and also edit existing pathways
PANTHER [26] Yes No Reviewed
by Curation
Coordinator
SBML, SBGN, PNG No Allows community pathway curation and also
provides links to Applied Biosystems genomic
products
CST, Cell Signaling Technology; PID, Pathway Interaction Database; STKE, Signal Transduction Knowledge Environment.
Kandasamy et al. Genome Biology 2010, 11:R3
http://genomebiology.com/2010/11/1/R3
Page 4 of 9in turn phosphorylate IL-2Rb and induce tyrosine phos-
phorylation of STATs (signal transducers and activators
of transcription) and various other downstream targets
[40]. The downstream signaling pathway also involves
mitogen-activated protein kinase and phosphoinositide
3-kinase signaling modules [41], leading to both mito-
genic and anti-apoptotic signals [40-42].
The IL-2 signaling pathway currently comprises of 68
proteins, 155 reactions with 68 molecular association
events, 76 enzymatic catalysis events and 11 transloca-
tion events. Importantly, 840 transcriptionally regulated
events - that is, a list of genes up- or down-regulated by
IL-2 - have been annotated from the published litera-
ture. In all, the reactions in the IL-2 pathway are sup-
ported by 1,289 links to research articles. Figure 2
shows the pathway page of the IL-2 pathway.
Integration of pathway information with other resources
The pathways developed by us have been integrated
with the Human Protein Reference Database (HPRD)
[43,44]. The integration of pathways in HPRD helps
identify each component of the pathway in the context
Figure 2 The IL-2 pathway page in NetPath. Hyperlinks to pathway-specific information, such as reactions, transcriptionally regulated genes,
molecular associations, and catalysis events, are listed. There is also an option to download pathway information in various data exchange
formats from this page.
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our community participation with other databases/
resources, we hope to establish connections with other
pathway databases such as KEGG [27] and Reactome
[16] in the future.
Availability of pathway data
A digital representation of pathways is essential to be
able to manipulate the large amount of available infor-
mation [4]. The diversity among pathway databases is
also reflected in differences in data models, data access
methods and file formats. This leads to the incompat-
ibility of data formats for the analysis of pathway data.
To avoid this, data standards are adopted by many of
the pathway databases [12,46]. Data standards reduce
the total number of translation operations needed to
exchange data between multiple sources. To facilitate
easy information retrieval from a wide variety of path-
way resources, a broad effort in the biological pathways
community called BioPAX was initiated. Since many
less-detailed data types in a pathway database are diffi-
cult to represent in a very detailed format, BioPAX
ontology uses hierarchical entity classes to present mul-
tiple levels of data resolution. All pathways in NetPath
are available for download in BioPAX level 2, version
1.0. The PSI-MI format was developed to exchange
molecular interaction data between databases containing
protein-protein interactions. PSI-MI data representation
facilitates data comparison, exchange and verification
[8]. The molecular interaction subset of NetPath path-
ways is also available in PSI-MI version 2.5. SBML was
developed as a medium for representation and exchange
of biochemical network models [9]. NetPath provides all
pathway data in SBML version 2.1 format. All data are
made available under the Creative Commons license
version 2.5 [47], which stipulates that the pathways may
be freely used if adequate credit is given to the authors.
Support for these data standards and free license enables
the integration of knowledge from multiple sources in a
coherent and reliable manner.
Enabling semantic web for NetPath
The semantic web envisions an internet where specific
information can be obtained from the web automatically
using computers. Because providing computers with the
intuitiveness of humans is nearly impossible as of now,
creation of meta-data - data about data - can help com-
puters identify what is being sought less ambiguously.
However, annotating more data does not automatically
imply that the data can be made easily accessible by the
user. For instance, although many resources permit
direct querying of individual molecules in the respective
databases, queries based on ‘relationships’ between dif-
ferent entries in the databases cannot be handled. One
possible solution to enable searching by such ‘concepts’
is to incorporate semantic web features that explicitly
describe the inter-relationship between entries in the
databases.
The W3C has established SPARQL as the standard
semantic query language. Pathway data in BioPAX uses
the web ontology language (OWL) format, which is
highly descriptive in nature and can be used to make
pathways semantically ‘queryable’.I nt h i sr e g a r d ,w e
have implemented an application programming interface
(API) for NetPath that accepts SPARQL over HTTP to
query the BioPAX files describing NetPath pathways.
The return results are provided in SPARQL Query
Results XML format. Although biologists cannot be
expected to write SPARQL queries, the ability to send
SPARQL queries over HTTP allows bioinformaticians to
write client applications that can retrieve NetPath
resources taking advantage of the descriptive richness of
SPARQL and BioPAX.
Analyzing impact factor for pathways
It is becoming clear that pathway information can be
used in the context of genome-scale gene expression
experiments. A novel approach has been recently
reported to measure the biological impact of perturba-
tion of pathways in genomewide gene expression experi-
ments [48]. This approach considers the topology of
genes in a pathway in conjunction with classical statis-
tics for microarray analysis. The impact factor is a statis-
tical approach that can capture the magnitude of the
expression changes of each gene, the position of the dif-
ferentially expressed genes on the given pathways, the
topology of the pathway that describes how these genes
interact, and the type of signaling interactions between
them. Our previous results using KEGG pathways were
found to correlate with known biological events that
were missed by other widely used classical analysis
methods. However, this approach could not be applied
to study immune responses because of the limited avail-
ability of data on such pathways in humans.
As a proof of principle, we selected publicly available
mRNA expression datasets from Gene Expression
Omnibus (GEO), a repository for gene expression data
[49]. Datasets that include expression analysis of
immune cells under different experimental conditions
were selected for this purpose.
One of the datasets used [GEO:GDS2214] (as
d e s c r i b e di n[ 5 0 ] )w a sa ne x p e r i m e n t a ls t u d yo fm R N A
expression analysis of neutrophils isolated from blood of
patients with sepsis-induced acute lung injury. The neu-
trophils were cultured with either lipopolysaccharide
(LPS) or high mobility group box protein 1 (HMGB1),
both of which are known to be mediators of the inflam-
matory response. Gene expression analysis was carried
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U133 Array Set HG-U133A oligonucleotide gene chip.
The authors found enhancement of nuclear transloca-
tion activity of NF-kappaB and phosphorylation of Akt
and p38 mitogen-activated protein kinase upon stimula-
tion of LPS or HMGB1. We carried out impact factor
analysis using this dataset on all ten immune signaling
pathways. The results corroborate with these findings
since IL-1 and IL-6 pathway scores are highly affected
while the rest of the NetPath pathways did not show
significant scores.
Another dataset selected [GEO:GDS1407] (described
in [51]) was a part of the gene expression study that
screened a cohort of 102 healthy individuals to investi-
gate the distribution of inflammatory responses to LPS
in the normal population in circulating leukocytes.
Expression profiling with Affymetrix U95AV2 oligonu-
cleotide microarray identified differentially regulated
genes between two phenotypic subgroups that have
been described as high LPS responders (lpshigh)a n dl o w
LPS responders (lpslow), based on the concentration of
cytokines produced in response to LPS. Gene expression
analysis was done using the Affymetrix U95AV2 human
oligonucleotide arrays. Impact factor analysis was carried
out using this dataset on all ten immune signaling path-
ways. Impact factor scores for IL-1 and IL-6 NetPath
pathways in the lpshigh group have high values whereas
impact factor scores for lpslow do not show any signifi-
cant perturbation of NetPath pathways. The scores are
consistent with experimental results showing upregula-
tion of IL-1 and IL-6 ligands in the lpshigh group. The
impact factor gives the insight that not only are the
ligands upregulated, but the pathway also seems to be
highly affected. It should be noted that impact factor is
not the only method to measure the biological impact
of perturbation of pathways and other methods will con-
tinue to be developed and could be applied to such
pathway data.
Outlook
In addition to keeping these pathways updated on a reg-
ular basis, we will also add additional pathways to Net-
P a t h .W ea l s oh o p et oi n v o l v et h eb i o m e d i c a l
community by allowing researchers to provide feedback
as well as to volunteer to become ‘pathway authorities’
on specific pathways, similar to the successful contribu-
tion model of the BioCarta resource [14]. In this regard,
we have already recruited several investigators to serve
as pathway authorities in our initial effort. Multiple
pathway authorities are possible for the same pathway if
there are enough interested investigators with expertise
who wish to contribute in this fashion. For instance, ten
other signaling pathways pertaining to cancer signaling
were developed for the Cancer Cell Map project [11], as
a collaboration with Memorial Sloan-Kettering Cancer
Center, and these data are also available through Path-
way Commons [52]. We also intend to map our human-
specific pathway data to corresponding mouse orthologs
to create the mouse equivalent of our signaling path-
ways. Since large amounts of human signaling pathway
data are modeled using the mouse, this will facilitate
biological system modeling that relies on primary
experimental data. We also intend to incorporate path-
way visualization for all existing pathways in NetPath as
well as those that will be added in the future using the
PathVisio software [53]. PathVisio also supports visuali-
zation of gene expression data in the context of path-
ways, which will enable biologists to display a systems
view of the signaling pathway.
Conclusions
We have developed a resource for integration of
human cellular signaling events. These pathway-speci-
fic protein-protein interaction data can be used to gen-
erate larger physical networks of protein-protein
interactions that, when coupled with data on genetic
interactions, could help in defining novel functional
relationships among proteins. In addition, genetic
interactions can functionally link proteins that belong
to unconnected physical networks. These pathways
c o u l da l s ob eu s e dt oi n t e r r o gate gene expression sig-
natures in cancers and other human diseases to better
understand the mechanisms or to obtain profiles for
diagnostic or therapeutic purposes. There is a large
amount of known information about different cellular
signaling pathways controlling a variety of cellular
functions, which is difficult to collect by one group.
We support the vision of many data providers collect-
ing data of interest and making them freely available
in standard formats as a scalable way to represent all
known pathway information in databases for compre-
hensive analysis. Overall, we hope to engage the bio-
medical community in keeping the NetPath pathway
resource up to date and as error-free as possible.
Materials and methods
The initial annotation process of any signaling pathway
involves gathering and reading of review articles to
achieve a brief overview of the pathway. This process
is followed by listing all the molecules that arereported
to be involved in the pathway under annotation. Infor-
mation regarding potential pathway authorities are also
gathered at this initial stage. Pathway experts are
involved in initial screening of the molecules listed to
check for any obvious omissions. In the second phase,
annotators manually perform extensive literature
searches using search keys, which include all the alter-
native names of the molecules involved, the name of
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addition, the iHOP [54] resource is also used to per-
form advanced PubMed-based literature searches to
collect the reactions that were reported to be impli-
cated in a given pathway. The collected reactions are
manually entered using the PathBuilder [6] annotation
interface, which is subjected to an internal review pro-
cess involving PhD level scientists with expertise in the
areas of molecular biology, immunology and biochem-
istry. However, there are instances where a molecule
has been implicated in a pathway in a published report
but the associated experimental evidence is either
weak or differs from experiments carried out by other
groups. For this purpose, we recruit several investiga-
tors as pathway authorities based on their expertise in
individual signaling pathways. The review by pathway
authorities occasionally leads to correction of errors
or, more commonly, to inclusion of additional infor-
mation. Finally, the pathway authorities help in asses-
sing whether the work of all major laboratories has
been incorporated for the given signaling pathway.
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